An ISHLT consensus statement on strategies to prevent?and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device

已完结 10 由 lzq 发布于 2026/4/3 20:29:21

DOI:10.1016/j.healun.2024.04.065
作者：Ian B. Hollis PharmD , Douglas L. Jennings PharmD , Selim Krim MD , Van-Khue Ton MD, PhD , Anique Ducharme MD, MSc , Jennifer Cowger MD , Mary Looby PharmD , J.J. Eu
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.healun.2024.04.065

Elsevier

Abstract：Life expectancy of patients with a durable, continuous-flow left ventricular assist device (CF-LVAD) continues to increase. Despite significant improvements in the delivery of care for patie

应助信息

20小时前

性感辣妹子长年在线

ca65af0b2f5811f1abf634735aa3bc31.pdf 已采纳

20小时前

Book学术机器人

2026/4/3 20:29:21 未找到该文献，机器人已退出，请等待人工下载

2026/4/3 20:29:21 Book学术AI机器人收到请求，开始寻找文献

2026/4/3 20:29:21 已向机器人发送请求

20小时前

lzq 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库What rheumatology can learn from oncology: a patient’s perspective